The manufacturer of devices for treatment of atrial fibrillation (irregular heartbeats) tentatively settled with the US Department of Justice allegations of false claims for $3.8 million.  The DOJ claimed that the manufacturer, AtriCure, marketed its devices beyond the scope of its FDA clearance and by instructing hospitals to use incorrect Medicare billing codes. 

More information about the lawsuit can be found at the following link:  http://news.Cincinnati.com/article/20091104/BIZ01/911050303/1076/BIZ/Atricure+pays++

This entry was posted on Friday, November 20th, 2009 at 4:38 pm and is filed under Federal False Claims Act, Healthcare. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.